Compare IPST & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IPST | NUWE |
|---|---|---|
| Founded | 2011 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0M | 3.2M |
| IPO Year | 2024 | 2012 |
| Metric | IPST | NUWE |
|---|---|---|
| Price | $2.95 | $0.75 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 278.5K | ★ 2.6M |
| Earning Date | 11-17-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $8,402,488.00 | $8,270,000.00 |
| Revenue This Year | $66.82 | $19.32 |
| Revenue Next Year | $60.33 | $12.01 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 5.41 | N/A |
| 52 Week Low | $0.24 | $0.08 |
| 52 Week High | $25.34 | $6.40 |
| Indicator | IPST | NUWE |
|---|---|---|
| Relative Strength Index (RSI) | 45.53 | 41.23 |
| Support Level | $2.30 | $0.71 |
| Resistance Level | $3.95 | $1.20 |
| Average True Range (ATR) | 0.50 | 0.09 |
| MACD | 0.04 | 0.02 |
| Stochastic Oscillator | 27.07 | 5.41 |
IP Strategy Holdings Inc operate a diversified business centered on digital asset-based infrastructure and intellectual property (IP) management, supplemented by a legacy craft spirits operating segment. The Company provides public market investors with broad exposure to the around $80 trillion programmable intellectual property economy in a regulated equity format. Its treasury reserve of $IP tokens provides direct participation in the Story ecosystem, which enables on-chain registration, licensing, and monetization of intellectual property.
Nuwellis Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.